CASCADE INVESTMENT ADVISORS, INC. Eli Lilly and Company Transaction History

CASCADE INVESTMENT ADVISORS, INC. portfolio value:

$0
portfolio value

CASCADE INVESTMENT ADVISORS, INC. quarter portfolio value change:

-0.27%
quarter

Eli Lilly and Company 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -425 shares -137.79K $323.35 0
Q2 2022 share 0.00% 0 shares 16.09K $324.23 425
Q1 2022 share Increase +6.25% 25 shares 11.21K $286.37 425
Q4 2021 share 0.00% 0 shares 18.06K $277.25 400
Q3 2021 share 0.00% 0 shares 612 $230.3 400
Q2 2021 share 0.00% 0 shares 17.08K $228.04 400
Q1 2021 share 0.00% 0 shares 7.19K $184.81 400
Q4 2020 share 0.00% 0 shares 8.32K $166.32 400
Q3 2020 share 0.00% 0 shares -6.46K $145.05 400
Q2 2020 share 0.00% 0 shares 10.18K $160.1 400
Q1 2020 share 0.00% 0 shares 2.91K $134.64 400
Q4 2019 share 0.00% 0 shares 7.84K $126.91 400
Q3 2019 share 0.00% 0 shares 416 $107.36 400
Q2 2019 share 0.00% 0 shares -7.58K $105.74 400
Q1 2019 share 0.00% 0 shares 5.61K $123.17 400
Q4 2018 share 0.00% 0 shares 3.36K $109.26 400
Q3 2018 share 0.00% 0 shares 8.79K $100.8 400
Q2 2018 share Increase 0.00% 400 shares 34.13K $79.72 400